AQST - Aquestive Therapeutics Inc. (AQST) CEO Keith Kendall on Q3 2020 Results - Earnings Call Transcript

Aquestive Therapeutics, Inc. (AQST) Q3 2020 Results Earnings Conference Call November 05, 2020, 08:00 AM ET Company Participants Stephanie Carrington - IR, Westwicke Keith Kendall - President and Chief Executive Officer John Maxwell - SVP and Chief Financial Officer Dan Barber - SVP and Chief Operating Officer Ken Marshall - SVP and Chief Commercial Officer Conference Call Participants Gary Nachman - BMO Capital Markets Andreas Argyrides - Wedbush Thomas Flaten - Lake Street Capital Presentation Operator Ladies and gentlemen, thank you for standing by, and welcome to the Q3 2020 Aquestive Therapeutics Inc. earnings conference call. At this time, all participants are in a listen-only mode. After the speakers' presentation, there will be a question-and-answer session. [Operator instructions] Please be advised, that today’s conference is being recorded. [Operator Instructions] I would now like to hand the conference over to your speaker today, Stephanie Carrington, Westwood, Investor Relations. Thank you. Please

For further details see:

Aquestive Therapeutics, Inc. (AQST) CEO Keith Kendall on Q3 2020 Results - Earnings Call Transcript